Rating: HOLD
| Metric | Value |
|---|---|
| Current Price | $97 |
| Triangulated Fair Value | $83 |
| 12-mo Scenario PWEV | $98 |
| Implied Return | -14% |
| Forward P/E | 25.7x |
| Market Cap | $23B |
| 52-Week Range | $81 – $106 |
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
Investment Thesis
The bull case — 'Bull — Defensive Re-Rate' (8% weight) — targets $155, +60% vs spot. It needs the multiple to hold or expand.
The dashboard below is the whole argument on one page: spot ($97) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Structural — Private-Label / Brand Erosion' (20%) — targets $45, -53% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
P/E Multiple explains 54% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.53 vs analyst floor +0.00 → delta +0.53 (n=22 mgmt / 15 Q&A; 79th pctile across the S&P book, z +0.8).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.53 | +0.00 | +0.53 |
| 2025Q4 | +0.75 | — | — |
| 2025Q3 | +0.39 | +0.23 | +0.16 |
| 2025Q2 | +0.52 | +0.33 | +0.19 |
News (last 365d, 905 articles): avg ticker sentiment +0.15 (bullish 16% / bearish 2%)
Scenario Analysis
The tree runs from a structural 'Structural — Private-Label / Brand Erosion' downside ($45) to a 'Bull — Defensive Re-Rate' bull case ($155); the probability-weighted blend (PWEV $98) is +1% versus spot.
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Structural — Private-Label / Brand Erosion | 20% | $45 | -53% |
| Consumer / Input Recession | 18% | $81 | -17% |
| Base — Pricing-Led Organic Growth | 34% | $105 | +8% |
| Growth — Premium Innovation + EM | 20% | $132 | +36% |
| Bull — Defensive Re-Rate | 8% | $155 | +60% |
| Probability-Weighted (PWEV) | — | $98 | +1% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Private-Label / Brand Erosion (20%, $45). Structural impairment — private-label / brand erosion: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 45.48; probability: 0.2.
- Consumer / Input Recession (18%, $81). Cyclical downturn — branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) weakens for 1–2 years before normalising. Drivers — implied_target: 80.81; probability: 0.18.
- Base — Pricing-Led Organic Growth (34%, $105). Mid-cycle — normalised branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail); disciplined capital allocation; steady returns. Drivers — implied_target: 104.56; probability: 0.34.
- Growth — Premium Innovation + EM (20%, $132). Upside — premium innovation + emerging markets lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 132.02; probability: 0.2.
- Bull — Defensive Re-Rate (8%, $155). Upside tail — sustained tight conditions or a structural re-rate on premium innovation + emerging markets. Drivers — implied_target: 155.28; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $88 | -9% |
| Peer P/E re-rate | multiple | $57 | -41% |
| Peer EV/Revenue re-rate | multiple | $58 | -40% |
| Scenario PWEV | multiple | $98 | +1% |
| DCF (5-year + terminal) | cash flow + terminal × | $79 | -19% |
| Triangulated (weighted) | — | $83 | -14% |
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $88 and 41% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (54% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 7.5%, 22x terminal FCF multiple → $79. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 15.13x) implies $57. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is wide (genuine disagreement — low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|
| Household & Personal Care | $6.2B | 100% | 4% | 18% | 26x | 3% | ESTIMATE |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) |
| net_debt_or_cash_b | -1.87 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.03 |
| div_yield | 0.0121 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | private-label / brand erosion |
| upside | premium innovation + emerging markets |
Industry Context — Consumer Staples — Household
This name sits in the Consumer Staples — Household as a household_personal. branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: PG (household_personal) · CL (household_personal) · KVUE (household_personal) · KMB (household_personal) · EL (household_personal) · CHD (household_personal) · CLX (household_personal)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Structural — Private-Label / Brand Erosion | 38% | 38% | |
| Mid-Cycle — Pricing-Led Organic Growth | 34% | 34% | |
| Upside — Premium Innovation / EM | 28% | 28% |
On the cluster's key downside — Structural — Private-Label / Brand Erosion () — this name implies 38% vs the cluster house view of 38% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The staples_household cycle is the shared macro driver. Driver — branded HPC pricing power + organic volume + input costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $6B | $1B | $0B | $0B | $1B | $1B |
| FY+2 | $7B | $1B | $0B | $0B | $1B | $1B |
| FY+3 | $7B | $1B | $0B | $0B | $1B | $1B |
| FY+4 | $7B | $1B | $0B | $0B | $1B | $1B |
| FY+5 | $7B | $1B | $0B | $0B | $1B | $1B |
| Terminal | — | — | — | — | $1B × 22x | $16B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 3% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 7.5% · Σ PV(FCF) $4B + PV(terminal) $16B = EV $21B; + net cash → equity $19B ÷ diluted shares 0.24B = $79/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $74/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 18% vs WACC 8% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| CL | 3.823x | 23.58x | 4% | 21% |
| KMB | 2.535x | 14.22x | 4% | 20% |
| CLX | 2.192x | 15.13x | 4% | 17% |
| Median | 2.535x | 15.13x | — | — |
Peer-median fwd P/E → $57; EV/Rev → $58.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $79 | 41% | $32 |
| Scenario PWEV | $98 | 29% | $29 |
| Monte Carlo median | $88 | 18% | $15 |
| Peer P/E | $57 | 12% | $7 |
| Triangulated | — | 100% | $83 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC ＼ Term× | 15.4x | 18.7x | 22.0x | 25.3x | 28.6x |
|---|---|---|---|---|---|
| 6% | $64 | $75 | $87 | $98 | $109 |
| 6% | $61 | $72 | $82 | $93 | $104 |
| 8% | $58 | $68 | $79 | $89 | $100 |
| 8% | $55 | $65 | $75 | $85 | $95 |
| 10% | $53 | $62 | $72 | $81 | $91 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ ＼ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $56 | $63 | $69 | $75 | $81 |
| -1.5pp | $60 | $67 | $74 | $80 | $87 |
| +0.0pp | $65 | $72 | $79 | $86 | $93 |
| +1.5pp | $69 | $77 | $84 | $92 | $99 |
| +3.0pp | $74 | $82 | $90 | $98 | $106 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $65 | $93 | $28 |
| Terminal × ±15% | $68 | $89 | $21 |
| Revenue CAGR ±3pp | $69 | $90 | $21 |
| WACC ±1pp | $75 | $82 | $7 |
| FCF conversion ±10% | $79 | $79 | $0 |
Company lever — SoP/share vs Household & Personal Care multiple (AI re-rating) (base 26x)
| Multiple | 18.2x | 22.1x | 26.0x | 29.9x | 33.8x |
|---|---|---|---|---|---|
| SoP/share | $468 | $570 | $672 | $774 | $876 |
Load-Bearing Assumptions
DCF: WACC 8%, terminal multiple 22×, FY+5 revenue $7B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
The valuation is multiple-dependent (54% of variance); a de-rating toward the DCF anchor ($79) implies -19%.
Fact / Inference / Speculation
- FACT: Spot $97; 52-week range $81–$106; engine rating HOLD; base-case target $98 (+1%).
- INFERENCE: Triangulated FV $83 (-14%). P/E Multiple explains 54% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
- SPECULATION: At current prices the embedded bet is that the multiple holds or expands — P/E Multiple carries 54% of outcome variance.
Recommendation: HOLD
Balanced: triangulated fair value $83 (-14% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple (54% of variance) — fundamentally a multiple/regime call. SBC runs —M TTM (disclosed in the appendix).